-
FACTORS ASSOCIATED WITH INFLAMMATION IN REPRIEVE TRIAL AMONG PEOPLE LIVING WITH HIV
Nov 01, 2023
-
PHASE 2 STUDY RESULTS OF SAB-185, A NOVEL POLYCLONAL ANTIBODY THERAPY FOR NONHOSPITALIZED ADULTS WITH COVID-19
Sep 07, 2023
-
ONE WEEK OF ORAL CAMOSTAT VERSUS PLACEBO IN NON-HOSPITALIZED ADULTS WITH MILD-TO-MODERATE COVID-19: A RANDOMIZED CONTROLLED PHASE 2 TRIAL
Aug 01, 2023
-
HEPB-CPG VACCINE PROVIDES PROTECTION TO PEOPLE LIVING WITH HIV AGAINST HEPATITIS B
Aug 01, 2023
-
PPMD – A MEDICATION INTERACTION CATEGORIZATION RESOURCE FOR CLINICAL TRIALS
Jul 01, 2023
-
ART INTENSIFICATION IS NOT EFFECTIVE AS A TREATMENT FOR NEUROCOGNITIVE IMPAIRMENT IN PEOPLE LIVING WITH HIV ON SUPPRESSIVE ART
Jul 01, 2023
-
ASSOCIATION BETWEEN METFORMIN USE AND COGNITIVE AND PHYSICAL FUNCTION IN PEOPLE LIVING WITH HIV AND DIABETES
Jun 01, 2023
-
REGULAR CANNABIS USE BY OLDER PEOPLE LIVING WITH HIV IS ASSOCIATED WITH A GREATER RISK OF IMPERFECT ADHERENCE TO ANTIRETROVIRAL THERAPY
Jun 01, 2023
-
ACTG STUDY FINDINGS SUGGEST NEED TO UPDATE WHO TREATMENT GUIDELINES FOR CRYPTOCOCCOL MENINGITIS
May 01, 2023
-
OPTIMIZING COMBINATION THERAPY AFTER TREATMENT FAILURE USING THE LATEST TECHNOLOGIES IN RESOURCE-LIMITED SETTINGS
May 01, 2023
-
DR 021: RISK FACTORS FOR HYPERTENSION EMERGING WITHIN ONE YEAR OF INITIATING ANTIRETROVIRAL THERAPY AMONG PEOPLE LIVING WITH HIV
Mar 01, 2023
-
BAMLANIVIMAB REDUCES NASAL VIRAL LEVELS AND INFLAMMATION BUT NOT SYMPTOM DURATION WHEN GIVEN FOR EARLY COVID-19 TREATMENT
Dec 01, 2022
